Tower Research Capital LLC (Trc) Nanobiotix S.A. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Nanobiotix S.A. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,921 shares of NBTX stock, worth $32,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,921Holding current value
$32,951% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NBTX
# of Institutions
17Shares Held
6.5MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$23.4 Million5.5% of portfolio
-
Perceptive Advisors LLC New York, NY266KShares$1.11 Million0.03% of portfolio
-
Black Rock Inc. New York, NY239KShares$994,2730.0% of portfolio
-
Old Mission Capital LLC48.5KShares$201,6510.0% of portfolio
-
Jane Street Group, LLC New York, NY23.3KShares$96,8570.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $145M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...